Veru to participate in the cantor oncology, hematology & hemeonc conference on september 28th, 2022

Miami, sept. 21, 2022 (globe newswire) -- veru inc. (nasdaq: veru), a biopharmaceutical company focused on developing novel medicines for covid-19 and other viral and ards-related diseases and for the management of breast and prostate cancers, today announced that the company will participate in the cantor oncology, hematology, hemeonc conference to be held at the lotte new york palace in new york city on wednesday, september 28, 2022.
VERU Ratings Summary
VERU Quant Ranking